Foreseen Biotechnology reposted this
Ipsen announces global licensing agreement with Foreseen Biotechnology, adding second pre-clinical ADC to its portfolio
We are an emerging biotechnology company that pioneered a high throughput integrated translational proteomics platform powered by AI-based data analytical system to accelerate discovery of novel targets for therapeutics and diagnostics that are clinically relevant. We are building a pipeline of novel product candidates for the diagnosis and treatment of cancer, inflammatory/autoimmune diseases and neurological disorders. Foreseen Biotechnology is incubated by Nest.Bio Ventures.
External link for Foreseen Biotechnology
Foreseen Biotechnology reposted this
Ipsen announces global licensing agreement with Foreseen Biotechnology, adding second pre-clinical ADC to its portfolio
We are proud to announce global licensing agreement with Ipsen for antibody-drug conjugate with first-in-class potential. We look forward to continuing the collaboration with our partner Ipsen.
Ipsen announces global licensing agreement with Foreseen Biotechnology, adding second pre-clinical ADC to its portfolio. Learn more: https://lnkd.in/d-hbdhSA